Exploring the Effect and Mechanism of the Novel Chinese Medicine Therapy (Gb-2 and Their Active Integrates) on Sars-Cov-2 Omicron Subvariants and Post-Acute Covid-19 Syndrome-From in Silicon Study, in Vitro and in Vivo Study to Real World Evidence Research

Project: National Science and Technology Council › National Science and Technology Council Academic Grants

Project Details

Abstract

此計畫將提供創新中醫藥療法(GB-2) 與其活性成分對於新冠病毒Omicron變異株及急性新冠肺炎後症候群作用的更多證據。更進一步，會將建立一個嶄新的平台，用結合電腦模擬研究，細胞及動物實驗，與真實世界數據探討之研究開發出更多的中醫藥療法來治療新冠肺炎及急性新冠肺炎後症候群。

Project IDs

Project ID:PC11207-2250
External Project ID:NSTC112-2320-B182-022-MY3
StatusFinished
Effective start/end date01/08/23 → 31/07/24

Keywords

  • COVID-19
  • SARS-CoV-2
  • post-acute COVID-19 syndrome
  • Omicron variants

Access Project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint